tiprankstipranks
Arrowhead Pharmaceuticals (GB:0HI3)
LSE:0HI3
UK Market

Arrowhead Pharmaceuticals Stock Analysis & Ratings

GB:0HI3 Stock Chart & Stats

Day’s Range$31.5 - $31.495
52-Week Range$0.00 - $0.00
Previous Close$33.13
Volume561.00
Average Volume (3M)80.00
Market Cap$3.33B
P/E Ratio-17.9
Beta1.20
Next EarningsAug 09, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
Smart Score5
EPS (TTM)-1.75


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

GB:0HI3 FAQ

What was Arrowhead Pharmaceuticals’s price range in the past 12 months?
Arrowhead Pharmaceuticals lowest stock price was $0.00 and its highest was $0.00 in the past 12 months.
    What is Arrowhead Pharmaceuticals’s market cap?
    Arrowhead Pharmaceuticals’s market cap is $3.33B.
      What is Arrowhead Pharmaceuticals’s price target?
      The average price target for Arrowhead Pharmaceuticals is $73.14. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $100.00 ,the lowest forecast is $35.00. The average price target represents 132.23% Increase from the current price of $31.495.
        What do analysts say about Arrowhead Pharmaceuticals?
        Arrowhead Pharmaceuticals’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 7 Wall Streets Analysts.
          When is Arrowhead Pharmaceuticals’s upcoming earnings report date?
          Arrowhead Pharmaceuticals’s upcoming earnings report date is Aug 09, 2022 which is in 85 days.
            How were Arrowhead Pharmaceuticals’s earnings last quarter?
            Arrowhead Pharmaceuticals released its earnings results on May 10, 2022. The company reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.145 by $0.265.
              Is Arrowhead Pharmaceuticals overvalued?
              According to Wall Street analysts Arrowhead Pharmaceuticals’s price is currently Undervalued.
                Does Arrowhead Pharmaceuticals pay dividends?
                Arrowhead Pharmaceuticals does not currently pay dividends.
                What is Arrowhead Pharmaceuticals’s EPS estimate?
                Arrowhead Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does Arrowhead Pharmaceuticals have?
                Arrowhead Pharmaceuticals has 105,740,000 shares outstanding.
                  What happened to Arrowhead Pharmaceuticals’s price movement after its last earnings report?
                  Arrowhead Pharmaceuticals reported an EPS of $0.41 in its last earnings report, beating expectations of $0.145. Following the earnings report the stock price went down -3.219%.
                    Which hedge fund is a major shareholder of Arrowhead Pharmaceuticals?
                    Among the largest hedge funds holding Arrowhead Pharmaceuticals’s share is Farallon Capital Management, L.L.C.. It holds Arrowhead Pharmaceuticals’s shares valued at 21M.

                      ---

                      Arrowhead Pharmaceuticals Stock Analysis

                      The Arrowhead Pharmaceuticals stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                      Learn more about TipRanks Smart Score

                      Company Description

                      Arrowhead Pharmaceuticals

                      Arrowhead Pharmaceuticals, Inc. operates as a biopharmaceutical company. It develops medicines that treat intractable diseases by silencing the genes that cause them. The company was founded by R. Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

                      ---
                      Similar Stocks
                      Company
                      Price & Change
                      Follow
                      Alnylam Pharma
                      Arbutus Biopharma
                      Benitec Biopharma
                      Amgen
                      Bio-Path Holdings

                      Popular Stocks

                      ---
                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis